Skip to content
2000
Volume 21, Issue 5
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

Janus kinase-2 (JAK2) is a non-receptor tyrosine kinase that serves key roles as the intracellular signaling effector of the cytokine receptor, such as mediating effects of leptin, erythropoietin, interferon, and growth hormone. A lot of molecular underlying mechanisms of JAK2 participation are known, however, additional signaling mechanisms of its activation, regulation, and pleiotropic signaling roles are still being explored. Here, we review the current knowledge of JAK2-mediated cellular signaling at the molecular level. In the beginning, we will focus on the recent advances in JAK2 activation and regulation. A part of our review focuses on the JAK2 involvement in various diseases/conditions. Recent advances highlight the molecular regulatory mechanisms utilized by the JAK2 signaling, thus, enabling to consider alternative therapeutic strategies to treat various diseases/conditions mediated by JAK2 by using it as a therapeutic target.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/1566524020666201015144702
2021-06-01
2025-09-29
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/1566524020666201015144702
Loading

  • Article Type:
    Review Article
Keyword(s): cytokine receptor; hormones; intracellular signaling; Jak2; protein kinases; STAT
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test